A Phase 2, Open-label and Single-Blind Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2017
At a glance
- Drugs C 16G2 (Primary)
- Indications Dental caries
- Focus Therapeutic Use
- Sponsors C3J Therapeutics
- 17 Jul 2017 Status changed from not yet recruiting to recruiting.
- 03 Jul 2017 Planned initiation date changed from 28 Jun 2017 to 10 Jul 2017.
- 28 Jun 2017 New trial record